IR-News

AUSSENDER



Medigene AG
Ansprechpartner: Medigene PR/IR
Tel.: +49 - 89 - 20 00 33 - 33 01
E-Mail: investor@medigene.com

WEITERE IR-NEWS

08.04.2020 - 17:25 | Altech Advanced Materials AG
08.04.2020 - 15:53 | Ledgertech SE
08.04.2020 - 13:30 | 7C Solarparken AG
pta20200219029
Business news for the stock market

Medigene AG: Medigene participates at upcoming conferences


Munich/Martinsried (pta029/19.02.2020/22:00) - Medigene AG (FSE: MDG1, Prime Standard) today announces its participation at the following upcoming scientific and investor conferences. Medigene's management and/or scientists will be available for one-on-one meetings at these events.

CAR-TCR Summit Europe
Date: 24 - 27 February 2020
Location: London, UK

Immuno-Oncology Summit Europe
Date: 9 - 12 March 2020
Location: London, UK

BIO Europe Spring
Date: 23 - 25 March 2020
Location: Paris, France

- end of announcement -

++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in pre-clinical and clinical development.

For more information, please visit http://www.medigene.com

This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.

Contact Medigene AG
Dr Gary Waanders, Claudia Burmester, Dr Anna Niedl
Tel.: +49 89 2000 3333 01
email: investor@medigene.com

In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list.

(end)
emitter: Medigene AG
Lochhamer Straße 11
82152 Planegg/Martinsried
Germany
contact person: Medigene PR/IR
phone: +49 - 89 - 20 00 33 - 33 01
e-mail: investor@medigene.com
website: www.medigene.de
stock exchanges: regulated market in Frankfurt; free market in Dusseldorf, free market in Hamburg, free market in Hannover, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
ISIN(s): DE000A1X3W00 (share)
|
|
98.339 Abonnenten
|
178.918 Meldungen
|
72.871 Pressefotos

BUSINESS

08.04.2020 - 12:30 | pressetext.redaktion
08.04.2020 - 11:00 | TPA Steuerberatung GmbH
08.04.2020 - 10:40 | Heemann Vermögensverwaltung AG
08.04.2020 - 10:25 | ISHAP Personaldokumentations GmbH
08.04.2020 - 10:00 | INTERHOMES AG
Top